Eurepa Mf 2mg Tablet belongs to the therapeutic classification of Antidiabetic Agents. The primary composition for this medicine is Metformin 500 MG, Repaglinide 2 MG.

Some diabetic patients taking Eurepa MF 2 Tablet 10's may develop a rare but serious condition called lactic acidosis. In this condition, there is too much lactic acid accumulated in the blood. So, your liver and kidney proper functioning is required to eliminate excess lactic acid from the blood. You should not take Eurepa MF 2 Tablet 10's if you have kidney disease, as measured by a blood test. Eurepa MF 2 Tablet 10's may lower vitamin B12 levels, so try to have blood test annual blood and vitamin. Eurepa MF 2 Tablet 10's, when used with or without insulin, tends to lower the blood sugar level extremely. So, the doctor may lower the dose of insulin. Eurepa MF 2 Tablet 10's may lower your thyroid-stimulating hormone (TSH), so an annual check-up of TSH is suggested.